These molecular changes in both MCF-7 and ZR-75-1 cells by all three test compounds led us to infer that SXR can increase expression of p53 and several key p53 target genes associated with apoptosis and inhibition of cell proliferation in breast cancer cell lines. This evidence concerns the gene TP53 and breast cancer.